Cargando…
Virologic outcomes of HAART with concurrent use of cytochrome P450 enzyme-inducing antiepileptics: a retrospective case control study
BACKGROUND: To evaluate the efficacy of highly-active antiretroviral therapy (HAART) in individuals taking cytochrome P450 enzyme-inducing antiepileptics (EI-EADs), we evaluated the virologic response to HAART with or without concurrent antiepileptic use. METHODS: Participants in the US Military HIV...
Autores principales: | Okulicz, Jason F, Grandits, Greg A, French, Jacqueline A, George, Jomy M, Simpson, David M, Birbeck, Gretchen L, Ganesan, Anuradha, Weintrob, Amy C, Crum-Cianflone, Nancy, Lalani, Tahaniyat, Landrum, Michael L |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3119192/ https://www.ncbi.nlm.nih.gov/pubmed/21575228 http://dx.doi.org/10.1186/1742-6405-8-18 |
Ejemplares similares
-
Race/ethnicity and HAART initiation in a military HIV infected cohort
por: Johnson, Erica N, et al.
Publicado: (2014) -
Hepatitis B Vaccine Antibody Response and the Risk of Clinical AIDS or Death
por: Landrum, Michael L., et al.
Publicado: (2012) -
1566 Factors Associated with 10 Years of Continuous HIV Viral Load Suppression on HAART
por: Bello, Kathryn, et al.
Publicado: (2014) -
Cumulative Viral Load and Virologic Decay Patterns after Antiretroviral Therapy in HIV-Infected Subjects Influence CD4 Recovery and AIDS
por: Marconi, Vincent C., et al.
Publicado: (2011) -
Factors associated with 10 years of continuous viral load suppression on HAART
por: Bello, Kathryn J., et al.
Publicado: (2016)